Clinical Trial Update: Evaluation of the Effect of Liposomal L-Arg and Vit C Integration on Mitochondrial Function in Patients With Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating liposomal L-Arginine and vitamin C on mitochondrial function in patients with heart failure; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Liposomal L-Arginine (L-Arginine (liposomal formulation))
• Vitamin C (ascorbic acid)

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Heart Failure | Phase 3 | Status: RECRUITING